The size of the organs responsible for emitting and detecting sexual communication signals is a likely target for selection. Communication via bioluminescent signals in synchronous fireflies is a promising model to test hypotheses regarding differences between males and females in the effect of the size of signal emission and detection organs on fitness components. Synchronous firefly species congregate in large numbers during the mating season, displaying bioluminescent signals aimed at potential mates during relatively short nightly periods. Operational sex ratios are male-biased and, thus, the so-called typical sex roles (indiscriminate males and choosy females) are expected to evolve. We studied the synchronous firefly , a species that during the mating season congregates in forests of central Mexico offering a magnificent natural show that attracts numerous tourists. females have reduced wings (brachyptery) and cannot fly. Our field study tested the hypothesis that the male-biased operational sex ratio and the short daily mating period result in strong male-male competition that selects for males with larger lanterns and larger eyes, and against male mate choice, whereas female-female mate competition is absent and, thus, no selection on lantern or eye size is expected. Even though lantern, eye or body size do not predict the probability of being found in copula for either sex, sexual dimorphism in these features, along with allometric slopes of lantern size and assortative mating in terms of relative lantern size, support not only the hypothesis of intense sexual selection among males, but the possibility of subtle mechanisms of sexual selection among females. Trade-offs between investment in signaling (lanterns) versus detection (eyes) structures, or with pressures different from sexual selection such as those imposed by predators, are also likely to be important in shaping the evolution of sexual signaling in these fireflies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597648 | PMC |
http://dx.doi.org/10.7717/peerj.10127 | DOI Listing |
Biomimetics (Basel)
November 2024
School of Electrical and Mechanical Engineering, The University of Adelaide, Adelaide 5005, Australia.
The Lunarminer framework explores the use of biomimetic swarm robotics, inspired by the division of labor in leafcutter ants and the synchronized flashing of fireflies, to enhance lunar water ice extraction. Simulations of water ice extraction within Shackleton Crater showed that the framework may improve task allocation, by reducing the extraction time by up to 40% and energy consumption by 31% in scenarios with high ore block quantities. This system, capable of producing up to 181 L of water per day from excavated regolith with a conversion efficiency of 0.
View Article and Find Full Text PDFMath Biosci
December 2024
Louisiana State University Health Sciences Center, Department of Cell Biology and Anatomy, New Orleans, LA, 70112, USA. Electronic address:
Phase Response Curves (PRCs) have been useful in determining and analyzing various phase-locking modes in networks of oscillators under pulse-coupling assumptions, as reviewed in Mathematical Biosciences, 226:77-96, 2010. Here, we update that review to include progress since 2010 on pulse coupled oscillators with conduction delays. We then present original results that extend the derivation of the criteria for stability of global synchrony in networks of pulse-coupled oscillators to include conduction delays.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
September 2024
Developmental Biology Unit, European Molecular Biology Laboratory, Heidelberg 69117, Germany.
Biomedicines
June 2024
Drug Development Unit (DDU), STALICLA SA, Campus Biotech Innovation Park, Avenue de Sécheron 15, 1202 Geneva, Switzerland.
This study aimed to evaluate the safety and tolerability of STP1, a combination of ibudilast and bumetanide, tailored for the treatment of a clinically and biologically defined subgroup of patients with Autism Spectrum Disorder (ASD), namely ASD Phenotype 1 (ASD-Phen1). We conducted a randomized, double-blind, placebo-controlled, parallel-group phase 1b study with two 14-day treatment phases (registered at clinicaltrials.gov as NCT04644003).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!